Swiss Re EBITDA 2012-2023 | SSREY

Swiss Re EBITDA for the quarter ending June 30, 2023 was $1.861B, a 6.39% decline year-over-year.

  • Swiss Re 2022 EBITDA was 5.015B, a 23.7% decline from 2021.
  • Swiss Re 2021 EBITDA was 6.573B, a 77.07% increase from 2020.
  • Swiss Re 2020 EBITDA was 3.712B, a 33.89% decline from 2019.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.

Swiss Re EBITDA 2012-2023 | SSREY

  • Swiss Re 2022 EBITDA was 5.015B, a 23.7% decline from 2021.
  • Swiss Re 2021 EBITDA was 6.573B, a 77.07% increase from 2020.
  • Swiss Re 2020 EBITDA was 3.712B, a 33.89% decline from 2019.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company NameMarket
Cap
Allianz SE (ALIZY)$121.1B
Zurich Insurance Group (ZURVY)$86.7B
Axa Sa (AXAHY)$82.4B
M¿nchener R¿ckversicherungs-Gesellschaft (MURGY)$69.4B
MetLife (MET)$60.1B
American (AIG)$46.8B
Prudential Financial (PRU)$42.4B
Hartford Financial Services (HIG)$32.4B
Sompo Holdings (SMPNY)$26.5B
Prudential Public (PUK)$21B
Loews (L)$18.8B
Principal Financial (PFG)$18.7B
Corebridge Financial (CRBG)$18.2B
Legal & General Group (LGGNY)$17.1B
Everest Group (EG)$15.6B
Aegon (AEG)$14B
Assurant (AIZ)$10.9B
Ageas SA (AGESY)$9.5B
Old Republic (ORI)$9.1B
MGIC Investment (MTG)$6.2B
Enact Holdings (ACT)$5B
Enstar Group (ESGR)$5B
Radian Group (RDN)$4.9B
Assured Guaranty (AGO)$4.7B
Scor SE (SCRYY)$4.5B
Kemper (KMPR)$4.2B
Goosehead Insurance (GSHD)$4.1B
CNO Financial (CNO)$4B
Oscar Health (OSCR)$3.9B
SiriusPoint (SPNT)$2.4B